Riverview Trust CO Moderna, Inc. Transaction History

Riverview Trust CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$85.37 - $115.44 $14,769 - $19,971	173 New	173 $18,000
Q3 2023 Oct 17, 2023	BUY	$96.41 - $126.61 $6,266 - $8,229	65 Added 31.4%	272 $28,000
Q2 2023 Jul 17, 2023	BUY	$118.5 - $160.53 $5,451 - $7,384	46 Added 28.57%	207 $25,000
Q1 2023 Apr 20, 2023	BUY	$135.66 - $197.02 $1,492 - $2,167	11 Added 7.33%	161 $24,000
Q4 2022 Jan 25, 2023	SELL	$118.38 - $210.04 $10,535 - $18,693	-89 Reduced 37.24%	150 $27,000
Q3 2022 Oct 27, 2022	BUY	$118.07 - $194.18 $4,722 - $7,767	40 Added 20.1%	239 $28,000
Q2 2022 Jul 27, 2022	SELL	$117.13 - $176.59 $4,216 - $6,357	-36 Reduced 15.32%	199 $28,000
Q1 2022 Apr 21, 2022	BUY	$126.46 - $235.05 $29,718 - $55,236	235 New	235 $40,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Riverview Trust CO, based on Form 13F filings with the SEC.

Stay updated on Riverview Trust CO with notifications on news.